来自印第安纳波利斯的Mark Heiman博士在会上展示了一项新的控糖途径,这项新的治疗方法能够改变糖尿病前期和2型糖尿病患者的肠道微生物群,只用了四周时间,受试者不仅口服糖耐量得到改善,胆固醇和炎症标志物水平也得到降低。Heiman博士介绍说,以往的微生物研究都关注于分析粪便中的细菌类型,而我们的团队则把研究做得更加深入——“在粪便样本中,除了细菌之外,还能检测出什么?”我们在粪便中检测出了葡萄糖、乳酸盐和大量其他物质。从表面来看,与健康对照相比,糖尿病前期和2型糖尿病患者肠道微生物有显著不同。例如,糖尿病个体肠道微生物产生的维生素B12和维生素K Dr. Mark Heiman from Indianapolis demonstrated a new sugar-controlling approach at the conference. The new treatment can change the gut microflora in patients with pre-diabetes and type-2 diabetes in only four weeks. Not only did oral glucose tolerance improved, but cholesterol and inflammatory markers were also reduced. Dr Heiman said that while previous microbial research was focused on analyzing the types of bacteria in manure, our team went deeper into the study- “In the faecal sample, what can be detected in addition to the bacteria? ”We detected glucose, lactate and a host of other substances in our feces. On the face of it, there is a significant difference in gut microbiota between patients with pre-diabetes and type 2 diabetes as compared to healthy controls. For example, diabetics produce vitamin B12 and vitamin K from gut microbes